Metraipolis › archive › dc_fea7ca49a332
Efficacy and safety of stereotactic radiotherapy in patients with HER2-positive breast cancer brain metastases following intracranial oligoprogression — Europe PMC PMID:42404219
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42404219
- DOI
- 10.3389/fonc.2026.1819733
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T07:43:49.059Z
- SHA-256 of the archived text
ea9dde87c5cc483310b1a4828ff64aea58d05fa49c190aa2d735c130ad46aa6a- Stable URL of this page
https://metraipolis.com/documento/dc_fea7ca49a332
How to cite
Efficacy and safety of stereotactic radiotherapy in patients with HER2-positive breast cancer brain metastases following intracranial oligoprogression — Europe PMC PMID:42404219 — Europe PMC (en), https://europepmc.org/article/MED/42404219 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fea7ca49a332 (Metraipolis archive dc_fea7ca49a332, sha256 ea9dde87c5cc483310b1a4828ff64aea58d05fa49c190aa2d735c130ad46aa6a)
BibTeX
@misc{dcfea7ca49a332,
title = {Efficacy and safety of stereotactic radiotherapy in patients with HER2-positive breast cancer brain metastases following intracranial oligoprogression — Europe PMC PMID:42404219},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42404219},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fea7ca49a332; sha256 ea9dde87c5cc483310b1a4828ff64aea58d05fa49c190aa2d735c130ad46aa6a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42404219. Agents can read the archived copy with the MCP tool read_document.